Login

CUBIST PHARMACEUTICALS INC 3 SEC Filings

Filed On Filing
26 Sep 2013 Form 3: Martin Kenneth J, Director

No securities owned

27 Mar 2013 Form 3: DesRosier Thomas, SVP, Chief Legal Counsel & GC

No securities owned

14 Mar 2013 Form 3: Tomsicek Michael John, SVP & Chief Financial Officer

Holds 191 shares of Common Stock

10 Sep 2012 Form 3: Vink Patrick V.j.j., SVP & GM, International Bus.

No securities owned

12 Mar 2012 Form 3: Henney Jane E Md, Director

No securities owned

17 Feb 2012 Form 3: Lawton Alison Francis, Director

No securities owned

09 Dec 2011 Form 3: Cubist Pharmaceuticals Inc, 10% owner and 1 other · ADOLOR CORP

Holds 36,090,910 shares of Common Stock, par value $0.0001 per share

28 Jun 2011 Form 3: Laranjeira Charles Anthony, SVP, Technical Operations

No securities owned

22 Feb 2010 Form 3: Moulder Leon O Jr, Director

No securities owned

17 Feb 2009 Form 3: Stea Gregory, SVP, Commercial Operations

Holds 1.1739 shares of Common Stock

08 Dec 2008 Form 3: Vetticaden Santosh, SVP & Chief Medical Officer

No securities owned

24 Jun 2008 Form 3: Corrigan Mark, Director

No securities owned

16 Jun 2008 Form 3: Hutson Nancy J, Director

No securities owned

01 May 2008 Form 3: Joseph Tamara L, SVP, GC & Secretary

No securities owned

14 Feb 2008 Form 3: Gilman Steven C, Senior Vice President

Holds 2,000 shares of Common Stock

25 Sep 2006 Form 3: Soeters Martinus Hermanus, Director

No securities owned

06 Sep 2006 Form 3: Archer Gordon Lee, Director

No securities owned

12 Jun 2006 Form 3: Gregoire Sylvie, Director

No securities owned

09 Jun 2006 Form 3: Pullman William E, SVP, Chief Medical Officer
12 Aug 2005 Form 3: Fellows Lindon M, Senior Vice President

No securities owned

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support